Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04118985 · ClinicalTrials.gov registry record · NA
Compensatory Training to Support Brain Healthy Lifestyle Changes in Those at Risk for Alzheimer's Disease
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT04118985: Completed NA study, sponsored by Mayo Clinic.
NCT04118985 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04118985, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The Researchers are trying to better understand if behavioral interventions can help improve memory compensation and engagement in healthy lifestyle behaviors in those with memory concerns but normal mental status exam.
Primary Outcome
self-report and informant report if an informant is available of compensatory strategy use; range 0-148 with higher scores indicating more compensatory use
Interventions
- BEHAVIORAL Cognitive rehabilitation and health behavior change intervention
- BEHAVIORAL Self-implementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2019-10-10 |
| Est. Completion | 2020-10-30 |
| Phase | NA |
What the finished NCT04118985 record still lists
NCT04118985 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Cognitive rehabilitation and health behavior change intervention is the first listed.
NCT04118985 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04118985 about?
NCT04118985 is a clinical study titled "Compensatory Training to Support Brain Healthy Lifestyle Changes in Those at Risk for Alzheimer's Disease". The Researchers are trying to better understand if behavioral interventions can help improve memory compensation and engagement in healthy lifestyle behaviors in those with memory concerns but normal mental status exam.
What is the current status of trial NCT04118985?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2019-10-10. Estimated completion is 2020-10-30.
What interventions are being tested in trial NCT04118985?
The interventions under investigation include: Cognitive rehabilitation and health behavior change intervention (BEHAVIORAL), Self-implementation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04118985?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04118985's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI